These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34361561)

  • 21. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.
    Swanson C; Mellström D; Lorentzon M; Vandenput L; Jakobsson J; Rane A; Karlsson M; Ljunggren O; Smith U; Eriksson AL; Bélanger A; Labrie F; Ohlsson C
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4878-82. PubMed ID: 17698910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes.
    Ekström L; Cevenini L; Michelini E; Schulze J; Thörngren JO; Belanger A; Guillemette C; Garle M; Roda A; Rane A
    Eur J Clin Invest; 2013 Mar; 43(3):248-55. PubMed ID: 23294483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes.
    Kuehl GE; Bigler J; Potter JD; Lampe JW
    Drug Metab Dispos; 2006 Feb; 34(2):199-202. PubMed ID: 16258079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exemestane and Its Active Metabolite 17-Hydroexemestane Induce UDP-Glucuronosyltransferase (UGT) 2B17 Expression in Breast Cancer Cells.
    Chanawong A; Mackenzie PI; McKinnon RA; Hu DG; Meech R
    J Pharmacol Exp Ther; 2017 Jun; 361(3):482-491. PubMed ID: 28404691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modeling study of the testosterone metabolizing enzyme UDP-glucuronosyltransferase 2B17.
    Trane I; Sager G; Dietrichs ES; Westrheim Ravna A
    Bioorg Med Chem; 2021 Apr; 36():116060. PubMed ID: 33691270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes.
    Lazarus P; Zheng Y; Runkle EA; Muscat JE; Wiener D
    Pharmacogenet Genomics; 2005 Nov; 15(11):769-78. PubMed ID: 16220109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation.
    Schulze JJ; Lundmark J; Garle M; Skilving I; Ekström L; Rane A
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2500-6. PubMed ID: 18334593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
    Turgeon D; Carrier JS; Lévesque E; Hum DW; Bélanger A
    Endocrinology; 2001 Feb; 142(2):778-87. PubMed ID: 11159850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
    Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
    Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection.
    Pavan Kumar VV; Vinu MC; Ramani AV; Mullangi R; Srinivas NR
    Biomed Chromatogr; 2006 Jan; 20(1):125-32. PubMed ID: 16013036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Testosterone metabolism and doping test results].
    Laczmański Ł; Medraś M
    Endokrynol Pol; 2009; 60(1):58-62. PubMed ID: 19224506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios.
    Anielski P; Simmchen J; Wassill L; Ganghofner D; Thieme D
    Drug Test Anal; 2011 Oct; 3(10):645-51. PubMed ID: 21928278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.
    Dubois SG; Beaulieu M; Lévesque E; Hum DW; Bélanger A
    J Mol Biol; 1999 May; 289(1):29-39. PubMed ID: 10339403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of salicylic acid, arbutin and corticosteroids in skin whitening creams available in Pakistan using chromatographic techniques.
    Shams A; Khan IU; Iqbal H
    Int J Cosmet Sci; 2016 Aug; 38(4):421-8. PubMed ID: 26855207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics.
    Turgeon D; Carrier JS; Chouinard S; Bélanger A
    Drug Metab Dispos; 2003 May; 31(5):670-6. PubMed ID: 12695357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide.
    Hu DG; Gardner-Stephen D; Severi G; Gregory PA; Treloar J; Giles GG; English DR; Hopper JL; Tilley WD; Mackenzie PI
    Mol Pharmacol; 2010 Oct; 78(4):714-22. PubMed ID: 20628005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.
    Grosse L; Pâquet S; Caron P; Fazli L; Rennie PS; Bélanger A; Barbier O
    Cancer Res; 2013 Dec; 73(23):6963-71. PubMed ID: 24121496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Udp-glucuronosyltransferase 2b7 is the major enzyme responsible for gemcabene glucuronidation in human liver microsomes.
    Bauman JN; Goosen TC; Tugnait M; Peterkin V; Hurst SI; Menning LC; Milad M; Court MH; Williams JA
    Drug Metab Dispos; 2005 Sep; 33(9):1349-54. PubMed ID: 15980101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the UGT2B17 polymorphism on the steroid profile. Results of a crossover clinical trial in athletes submitted to testosterone administration.
    Martín-Escudero P; Muñoz-Guerra JA; García-Tenorio SV; Garde ES; Soldevilla-Navarro AB; Galindo-Canales M; Prado N; Fuentes-Ferrer ME; Fernández-Pérez C
    Steroids; 2019 Jan; 141():104-113. PubMed ID: 30503386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5'-diphospho-glucuronosyltransferase (UGT2B17) gene.
    Ekström L; Schulze JJ; Guillemette C; Belanger A; Rane A
    Pharmacogenet Genomics; 2011 Jun; 21(6):325-32. PubMed ID: 21383644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.